{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:10:32Z","timestamp":1765609832880,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Natural Science Foundation of the People\u2019s Republic of China","award":["81372587","81171886"],"award-info":[{"award-number":["81372587","81171886"]}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7132018"],"award-info":[{"award-number":["7132018"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing City Board of Education Development Project","award":["KZ201310025021"],"award-info":[{"award-number":["KZ201310025021"]}]},{"name":"Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality","award":["IDHT20140514"],"award-info":[{"award-number":["IDHT20140514"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.toxlet.2018.02.019","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T13:06:38Z","timestamp":1518786398000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Downregulation of metabotropic glutamate receptor 5 inhibits hepatoma development in a neurotoxin rotenone-induced Parkinson\u2019s disease model"],"prefix":"10.1016","volume":"288","author":[{"given":"Xiao Xu","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao Song","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2018.02.019_bib0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2004.11.040","article-title":"Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP","volume":"1033","author":"Aguirre","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00702-013-1149-z","article-title":"A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease","volume":"121","author":"Ambrosi","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.parkreldis.2009.11.005","article-title":"Cancer risk in association with Parkinson disease: a population-based study","volume":"16","author":"Becker","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2008.06.073","article-title":"Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex","volume":"156","author":"Boer","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4161\/cbt.9.6.10898","article-title":"Glutamate receptors in pediatric tumors of the central nervous system","volume":"9","author":"Brocke","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-4159.2009.06454.x","article-title":"The PDZ domain protein CAL interacts with mGluR5a and modulates receptor expression","volume":"112","author":"Cheng","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0035","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.3390\/ijms150610892","article-title":"Activation of mGluR5 attenuates NMDA-induced neurotoxicity through disruption of the NMDAR-PSD-95 complex and preservation of mitochondrial function in differentiated PC12Cells","volume":"15","author":"Dai","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrc3150","article-title":"Parkinson's disease and cancer: two wars one front","volume":"11","author":"Devine","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1440-1681.12410","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats","volume":"42","author":"Ferrigno","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000000083","article-title":"Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease","volume":"82","author":"Fitzmaurice","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0060","doi-asserted-by":"crossref","first-page":"e19622","DOI":"10.1371\/journal.pone.0019622","article-title":"\u03b1-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease","volume":"6","author":"Israeli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jat.1413","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and d-galactosamine in mice","volume":"29","author":"Jesse","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0070","doi-asserted-by":"crossref","first-page":"35827","DOI":"10.1074\/jbc.M109.046276","article-title":"Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts","volume":"284","author":"Jong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0075","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1073\/pnas.0307588100","article-title":"Electrical wound-healing assay for cells in vitro","volume":"101","author":"Keese","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0960-9776(03)00061-4","article-title":"Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease","volume":"12","author":"Lalonde","year":"2003","journal-title":"Breast"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20834","article-title":"The Parkinson's complex: parkinsonism is just the tip of the iceberg","volume":"59","author":"Langston","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2010.07.009","article-title":"Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS\/JNK-dependent mitochondrial pathway","volume":"298","author":"Li","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12957-015-0646-y","article-title":"Status of the Parkinson's disease gene family expression in non-small-cell lung cancer","volume":"13","author":"Liu","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0100","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/brain\/awr137","article-title":"Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys","volume":"134","author":"Masilamoni","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(98)00189-4","article-title":"Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion","volume":"88","author":"Meshul","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neuropharm.2012.07.036","article-title":"MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates","volume":"66","author":"Morin","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6602279","article-title":"Atypical cancer pattern in patients with Parkinson's disease","volume":"92","author":"Olsen","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0120","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.ejca.2014.06.018","article-title":"Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study","volume":"50","author":"Ong","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0125","first-page":"81","article-title":"Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma","volume":"17","author":"Park","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0130","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.fct.2012.05.027","article-title":"Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways","volume":"50","author":"Park","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0135","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.41.5_Suppl_2.89","article-title":"Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look","volume":"41","author":"Tanner","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-005-2202-x","article-title":"Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease","volume":"179","author":"Turle-Lorenzo","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbadis.2011.11.008","article-title":"Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: a self-perpetuating crosstalk?","volume":"1822","author":"Vairetti","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0155","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1460-9568.2005.04362.x","article-title":"Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease","volume":"22","author":"Vernon","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0160","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.biochi.2012.06.006","article-title":"The suppressive effect of metabotropic glutamate receptor 5 (mGlu5) inhibition on hepatocarcinogenesis","volume":"94","author":"Wu","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.toxlet.2018.02.019_bib0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2015.09.017","article-title":"Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model","volume":"89","author":"Xia","year":"2015","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0170","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3892\/mmr.2015.4715","article-title":"Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells","volume":"13","author":"Zheng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.toxlet.2018.02.019_bib0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12031-011-9560-0","article-title":"Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus","volume":"47","author":"Zhu","year":"2012","journal-title":"J. Mol. Neurosci."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418300651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418300651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T02:41:51Z","timestamp":1565318511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427418300651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":35,"alternative-id":["S0378427418300651"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.02.019","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of metabotropic glutamate receptor 5 inhibits hepatoma development in a neurotoxin rotenone-induced Parkinson\u2019s disease model","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}